跳至主要内容
临床试验/NCT04014114
NCT04014114Unknown不适用

The Use of Digital Genetic Assistant (DGA) for Expanded Carrier Screening

Igentify Ltd0 个研究点目标入组 600 人开始时间: 2020年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
Igentify Ltd
入组人数
600
主要终点
Change in the number of post-test face-to-face/telephone genetic counseling sessions

研究概览

简要总结

The DGA provides an end-to-end digital solution to the preconception carrier screening process from participant registration to receipt of the test results and their interpretations. These steps are provided using personalized animated videos.

详细描述

Participant Enrollment (pre-test):

This system component enables the participant to start the process prior to the visit by enabling the participant to enter his/her personal information into the DGA system. This step is estimated to takes approximately ten minutes and is expected to save valuable time should they need to come for a genetic counseling session. Using this component, the medical questionnaire will self-adjust to address the clinical scenario related to each participant. This component will allow the attending physician to receive virtually all required information about the participant prior to their meeting, thereby improving communication with the participants, and potentially referring them to relevant tests even prior to their meeting. In the face-to-face meeting between the participants and the medical professional, most of the report summarizing treatment and family history, which the medical professional would have usually spent precious time filling, will be automatically ready, allowing for easy editing and finalization.

Next, the participant is guided through an on-line introductory personalized video explaining the genetic test and its implications tailored to the medical information that the participant entered in the questionnaire. The participant's understanding of the information presented in the personalized introductory video is tested by three questions. The participant must accurately answer the three questions. If the participant makes two mistakes the application opens the video in the relevant section and then asks the participant again. Following a successful completion of this step the participant is invited to sign an electronic Informed Consent to carry out the routine CarrierScan screening test (which is not a part of this study). The participants will re-sign a hard copy Informed Consent upon arrival to the Sheba Genetic Institute. A dedicated dashboard enables medical staff to monitor the progression of a participant along the process.

Step 1. Registration: During the initial phone call with potential participants, qualified staff that are part of the study will explain the process and extend an invitation to participated in the study. The DGA process will begin when the Sheba Medical Center (MC) Genetics Institute will send potential participants a link following the initial phone call between them. This link will enable the participant a secure connection to the DGA system. During the initial registration to the system the participant will undergo authentication using the standard two-factor authentication method based on phone number and the last four digits of the ID number of the participant. At the end of this process a new user will be created in the system.

Step 2. Interactive medical questionnaire: The interactive medical questionnaire is defined as the process of gathering personal information relevant to the specific clinical genetic scenario (e.g. personal information, personal and family medical information). The interactive medical questionnaire incorporated in the Enrollment app is based on Ministry of Health (MOH) guidelines for carrier screening. The questionnaire is dynamic and is interactively adapted based on live information supplied by the participant. In addition, the questionnaire is taking advantage of "natural language form", a user experience technique for drafting the questions, for a higher compliance rate. The questionnaire was approved by the Sheba MC PI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants willing to undergo expanded preconception carrier screening (CarrierScan Screening Test).
  • Participants willing to use the DGA as part of their genetic screening.
  • Participants willing to fill up questionnaires about their experience and understanding of the genetic counseling and share their clinical and DGA usage data with the study personnel.
  • Fluent in Hebrew.
  • Couples (Male + Female) that plan to have children together.
  • Age above 18.

排除标准

  • Individuals that undergo bone marrow transplantation.
  • Participants refusing to participate in the study.

结局指标

主要结局

Change in the number of post-test face-to-face/telephone genetic counseling sessions

时间窗: One year

The investigators expect a significant change in the number of post-test face-to-face/telephone genetic counseling sessions. The current practice of expanded carrier screening provides a genetic counseling session to each couple who one of them is found to be a carrier of a genetic disease. Following the CarrierScan, expanded carrier screening test, \~60% of the couples are expected to be carriers of at least one disease. Using the DGA, the investigators expect that in the vast majority of the cases (\>95%), when low risk is identified, the couple will be informed by the DGA without requiring a face-to-face/telephone session. The investigators expect that some of the low risk couples that received digital report will still request further counseling. The investigators estimate this fraction to be 10-20% of the low risk participants.

次要结局

未报告次要终点

研究者

发起方
Igentify Ltd
申办方类型
Industry
责任方
Sponsor

相似试验